MiMedx Group, Inc. (MDXG) DCF Valuation

Valoración de DCF de Mimedx Group, Inc. (MDXG)

US | Healthcare | Biotechnology | NASDAQ
MiMedx Group, Inc. (MDXG) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

MiMedx Group, Inc. (MDXG) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¿Busca evaluar el valor intrínseco de Mimedx Group, Inc.? Nuestra calculadora MDXG DCF integra datos del mundo real con extensas características de personalización, lo que le permite refinar sus pronósticos y mejorar sus estrategias de inversión.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 299.3 248.2 258.6 267.8 321.5 330.1 338.9 348.0 357.4 367.0
Revenue Growth, % 0 -17.05 4.18 3.57 20.03 2.68 2.68 2.68 2.68 2.68
EBITDA -12.3 -45.8 -1.9 -10.7 40.5 -9.7 -10.0 -10.2 -10.5 -10.8
EBITDA, % -4.13 -18.44 -0.7312 -3.99 12.6 -2.94 -2.94 -2.94 -2.94 -2.94
Depreciation 8.5 7.8 6.2 4.0 3.4 7.2 7.4 7.6 7.8 8.1
Depreciation, % 2.85 3.16 2.39 1.51 1.07 2.19 2.19 2.19 2.19 2.19
EBIT -20.9 -53.6 -8.1 -14.7 37.1 -16.9 -17.4 -17.9 -18.3 -18.8
EBIT, % -6.98 -21.59 -3.12 -5.5 11.54 -5.13 -5.13 -5.13 -5.13 -5.13
Total Cash 69.1 95.8 87.1 66.0 82.0 96.0 98.6 101.3 104.0 106.8
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 32.3 45.5 41.1 43.1 53.9
Account Receivables, % 10.81 18.32 15.89 16.09 16.76
Inventories 9.1 10.4 11.4 13.2 21.0 15.2 15.6 16.1 16.5 16.9
Inventories, % 3.04 4.17 4.4 4.92 6.54 4.62 4.62 4.62 4.62 4.62
Accounts Payable 8.7 8.8 7.4 8.5 9.0 10.1 10.4 10.6 10.9 11.2
Accounts Payable, % 2.91 3.53 2.86 3.16 2.81 3.05 3.05 3.05 3.05 3.05
Capital Expenditure -2.2 -4.6 -3.5 -2.7 -2.0 -3.7 -3.8 -3.9 -4.0 -4.1
Capital Expenditure, % -0.74117 -1.83 -1.34 -1 -0.61808 -1.11 -1.11 -1.11 -1.11 -1.11
Tax Rate, % -120.15 -120.15 -120.15 -120.15 -120.15 -120.15 -120.15 -120.15 -120.15 -120.15
EBITAT -20.9 -42.9 -8.3 -14.8 81.7 -16.3 -16.7 -17.1 -17.6 -18.1
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -47.3 -54.0 -3.6 -16.2 65.1 -3.4 -14.5 -14.9 -15.3 -15.7
WACC, % 13.6 13.51 13.6 13.6 13.6 13.58 13.58 13.58 13.58 13.58
PV UFCF
SUM PV UFCF -42.0
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -16
Terminal Value -139
Present Terminal Value -73
Enterprise Value -115
Net Debt -34
Equity Value -81
Diluted Shares Outstanding, MM 146
Equity Value Per Share -0.56

What You Will Receive

  • Pre-Filled Financial Model: MiMedx Group’s actual data facilitates accurate DCF valuation.
  • Comprehensive Forecast Control: Modify revenue growth, profit margins, WACC, and other essential parameters.
  • Real-Time Calculations: Automatic updates provide immediate feedback as you adjust inputs.
  • Professional-Grade Template: A polished Excel file crafted for high-quality valuation.
  • Flexible and Reusable: Designed for adaptability, allowing for repeated use in detailed forecasting.

Key Features

  • Customizable Financial Inputs: Adjust essential parameters such as revenue growth, gross margin %, and R&D expenses.
  • Instant DCF Valuation: Automatically computes intrinsic value, NPV, and additional metrics in real-time.
  • High-Precision Accuracy: Incorporates MiMedx's actual financial data for trustworthy valuation results.
  • Streamlined Scenario Analysis: Easily evaluate various assumptions and analyze results side by side.
  • Efficiency Booster: Avoid the hassle of creating intricate valuation models from the ground up.

How It Works

  1. Step 1: Download the Excel file for MiMedx Group, Inc. (MDXG).
  2. Step 2: Review MiMedx's pre-filled financial data and forecasts.
  3. Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model update in real-time as you adjust your assumptions.
  5. Step 5: Analyze the outputs and leverage the results for your investment decisions.

Why Choose This Calculator for MiMedx Group, Inc. (MDXG)?

  • Comprehensive Tool: Incorporates DCF, WACC, and financial ratio analyses tailored for MDXG.
  • Customizable Inputs: Modify yellow-highlighted cells to explore various financial scenarios.
  • Detailed Insights: Automatically calculates MiMedx’s intrinsic value and Net Present Value.
  • Preloaded Data: Historical and projected data provide reliable starting points for analysis.
  • Professional Quality: Perfect for financial analysts, investors, and business consultants focusing on MDXG.

Who Should Use This Product?

  • Investors: Accurately estimate MiMedx Group, Inc.'s (MDXG) fair value before making investment decisions.
  • CFOs: Leverage a professional-grade DCF model for financial reporting and analysis specific to MiMedx Group, Inc. (MDXG).
  • Consultants: Quickly adapt the template for valuation reports tailored to clients interested in MiMedx Group, Inc. (MDXG).
  • Entrepreneurs: Gain insights into financial modeling practices utilized by leading healthcare companies, including MiMedx Group, Inc. (MDXG).
  • Educators: Use it as a teaching tool to demonstrate valuation methodologies relevant to MiMedx Group, Inc. (MDXG).

What the Template Contains

  • Preloaded MDXG Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.